Sfoglia per Titolo
Hepatocellular dysplastic nodules
2007-01-01 Roncalli, M.; Borio, M.; Di Tommaso, L.
Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience.
2004-01-01 Roncalli, M.
Hepatocyte AgNOR protein quantitative expression is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis
1997-01-01 Trere, D; Borzio, M; Roncalli, M; Derenzini, M.
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12(low/neg) accessory cells with dendritic-cell features
2006-01-01 Rutella, S; Bonanno, G; Procoli, A; Mariott, A; de Ritis, Dg; Curti, A; Danese, S; Pessina, G; Pandolfi, S; Natoni, F; Di Febo, A; Scambia, G; Manfredini, R; Salati, S; Ferrari, S; Pierelli, L; Leone, G; Lemoli, Rm
Hepatocyte Nuclear Factor (HNF) 4α Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection.
2011-01-01 Ehehalt, F; Rümmele, P; Kersting, S; Lang-Schwarz, C; Rückert, F; Hartmann, A; Dietmaier, W; Terracciano, L; Aust, De; Jahnke, B; Saeger, Hd; Pilarsky, C; Grützmann, R
Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples
2004-01-01 Lugli, A; Tornillo, L; Mirlacher, M; Bundi, M; Sauter, G; Terracciano, L
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis
1998-01-01 Borzio, M; Trere, D; Borzio, F; Ferrari, Ar; Bruno, S; Roncalli, M; Colloredo, G; Leandro, G; Oliveri, F; Derenzini, M.
Hepatogastric inflammatory pseudotumor presumably deriving from prior amebic infection
2008-01-01 Alfieri, R; Alaggio, R; Ruol, A; Castoro, C; Cagol, M; Michieletto, S; Pomerri, F; Acquaviva, A; Ancona, E
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
2017-01-01 Orsi, E; Grancini, V; Menini, S; Aghemo, A; Pugliese, G
Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol
2003-01-01 Terracciano, L; Glatz, K; Mhawech, P; Vasei, M; Lehmann, Fs; Vecchione, R; Tornillo, L
Hepatorenal Syndrome and Novel Advances in its Management
2013-01-01 Fabrizi, F; Aghemo, A; Messa, P
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
2021-01-01 Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza
Hepatotoxicity of immune check point inhibitors: Approach and management
2019-01-01 Lleo, A; Rimassa, L; Colombo, M
HER 2 Expression as Prognostic Factor for Neoadjuvant Chemotherapy in Gastric and Esophago-Gastric Junction Adenocarcinoma
2012-01-01 M., Bissolati; E., Orsenigo; C., Socci; Chiari, D; J., Nifosi; L., Ghirardelli; S., Di Palo; C., Staudacher
HER 2 POSITIVE BREAST CANCER WITH CENTRAL NERVOUS METASTASES.PATHOLOGICAL FEATURES AND CLINICAL OUTCOME
2016-01-01 Tinterri, C
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization and immunohistochemistry
2003-01-01 Pellegrini, C.; Falleni, M.; Marchetti, A.; Cassani, B.; Miozzo, M.; Buttitta, F.; Roncalli, M.; Coggi, G.; Bosari, S.
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
2003-01-01 Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S.
HER2 gene status in primary breast cancers and matched distant metastases
2007-01-01 Tapia, C; Savic, S; Wagner, U; Schönegg, R; Novotny, H; Grilli, B; Herzog, M; Barascud, Ad; Zlobec, I; Cathomas, G; Terracciano, L; Feichter, G; Bubendorf, L
Her2 overexpression / amplification and neoadjuvant chemotherapy in gastric and esophagogastric junction adenocarcinoma
2013-01-01 Chiari, D; E., Orsenigo; L., Albarello; C., Socci; P., Gazzetta; M., Bissolati; E., Mazza; C., Staudacher
HER2 positive breast cancer with central nervous system metastases: Pathological features and clinical outcome
2016-01-01 Masci, G; Santarpia, L; Bottai, G; Giordano, L; Zuradelli, M; Torrisi, R; Di Tommaso, L; Sagona, A; Errico, V; Gatzemeier, W; Testori, A; Navarria, P; Bello, L; Tinterri, C; Scorsetti, M; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Hepatocellular dysplastic nodules | 1-gen-2007 | Roncalli, M.; Borio, M.; Di Tommaso, L. | |
| Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. | 1-gen-2004 | Roncalli, M. | |
| Hepatocyte AgNOR protein quantitative expression is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis | 1-gen-1997 | Trere, D; Borzio, M; Roncalli, M; Derenzini, M. | |
| Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12(low/neg) accessory cells with dendritic-cell features | 1-gen-2006 | Rutella, S; Bonanno, G; Procoli, A; Mariott, A; de Ritis, Dg; Curti, A; Danese, S; Pessina, G; Pandolfi, S; Natoni, F; Di Febo, A; Scambia, G; Manfredini, R; Salati, S; Ferrari, S; Pierelli, L; Leone, G; Lemoli, Rm | |
| Hepatocyte Nuclear Factor (HNF) 4α Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection. | 1-gen-2011 | Ehehalt, F; Rümmele, P; Kersting, S; Lang-Schwarz, C; Rückert, F; Hartmann, A; Dietmaier, W; Terracciano, L; Aust, De; Jahnke, B; Saeger, Hd; Pilarsky, C; Grützmann, R | |
| Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples | 1-gen-2004 | Lugli, A; Tornillo, L; Mirlacher, M; Bundi, M; Sauter, G; Terracciano, L | |
| Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis | 1-gen-1998 | Borzio, M; Trere, D; Borzio, F; Ferrari, Ar; Bruno, S; Roncalli, M; Colloredo, G; Leandro, G; Oliveri, F; Derenzini, M. | |
| Hepatogastric inflammatory pseudotumor presumably deriving from prior amebic infection | 1-gen-2008 | Alfieri, R; Alaggio, R; Ruol, A; Castoro, C; Cagol, M; Michieletto, S; Pomerri, F; Acquaviva, A; Ancona, E | |
| Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? | 1-gen-2017 | Orsi, E; Grancini, V; Menini, S; Aghemo, A; Pugliese, G | |
| Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol | 1-gen-2003 | Terracciano, L; Glatz, K; Mhawech, P; Vasei, M; Lehmann, Fs; Vecchione, R; Tornillo, L | |
| Hepatorenal Syndrome and Novel Advances in its Management | 1-gen-2013 | Fabrizi, F; Aghemo, A; Messa, P | |
| Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors | 1-gen-2021 | Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza | |
| Hepatotoxicity of immune check point inhibitors: Approach and management | 1-gen-2019 | Lleo, A; Rimassa, L; Colombo, M | |
| HER 2 Expression as Prognostic Factor for Neoadjuvant Chemotherapy in Gastric and Esophago-Gastric Junction Adenocarcinoma | 1-gen-2012 | M., Bissolati; E., Orsenigo; C., Socci; Chiari, D; J., Nifosi; L., Ghirardelli; S., Di Palo; C., Staudacher | |
| HER 2 POSITIVE BREAST CANCER WITH CENTRAL NERVOUS METASTASES.PATHOLOGICAL FEATURES AND CLINICAL OUTCOME | 1-gen-2016 | Tinterri, C | |
| HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization and immunohistochemistry | 1-gen-2003 | Pellegrini, C.; Falleni, M.; Marchetti, A.; Cassani, B.; Miozzo, M.; Buttitta, F.; Roncalli, M.; Coggi, G.; Bosari, S. | |
| HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma | 1-gen-2003 | Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S. | |
| HER2 gene status in primary breast cancers and matched distant metastases | 1-gen-2007 | Tapia, C; Savic, S; Wagner, U; Schönegg, R; Novotny, H; Grilli, B; Herzog, M; Barascud, Ad; Zlobec, I; Cathomas, G; Terracciano, L; Feichter, G; Bubendorf, L | |
| Her2 overexpression / amplification and neoadjuvant chemotherapy in gastric and esophagogastric junction adenocarcinoma | 1-gen-2013 | Chiari, D; E., Orsenigo; L., Albarello; C., Socci; P., Gazzetta; M., Bissolati; E., Mazza; C., Staudacher | |
| HER2 positive breast cancer with central nervous system metastases: Pathological features and clinical outcome | 1-gen-2016 | Masci, G; Santarpia, L; Bottai, G; Giordano, L; Zuradelli, M; Torrisi, R; Di Tommaso, L; Sagona, A; Errico, V; Gatzemeier, W; Testori, A; Navarria, P; Bello, L; Tinterri, C; Scorsetti, M; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile